| | |
ASPsiRNA information |
siRNA Id: | aspsirna0183
|
siRNA Name: | K12-L132P-13
|
Mismatch information |
Wild siRNA (As strand 3'->5'): | UUUUAGAAUUACUAUCUAA
|
ASP-siRNA (As strand 3'->5'): | UUUUAGGAUUACUAUCUAA
|
Mismatch position in siRNA: | G13A |
Gene Information |
Gene Name | Keratin 12 (KRT12) |
Target Sequence (5'->3'): | TCTGGATCAGAAAAAGAAACTATGCAAAATCTTAATGATAGAT
|
Wild allele (5'->3'): | AAAAUCUUAAUGAUAGAUU
|
Mutant allele (5'->3'): | AAAAUCCUAAUGAUAGAUU
|
Position of siRNA on target gene: | 413-431
|
Respective Gene/Protein Resources |
GenBank Accession: | NM_000223.3 |
Cytogenic location: | 17q21.2 |
Chromosomal coordinates: | 17:39,017,429-39,023,461 |
UniProt ID: | Q99456 |
HUGO ID: | 6414 |
Reference SNp(RefSNP): | rs58038639 |
Disease/Mutation information |
Target Mutation: | c.409G>C,p.Ala137Pro
|
Matation type/variant: | Single nucleotide variant/Missense variant
|
Mutation at gene level: | NG_008077.1:g.5433G>C
|
Pathogenic status of mutation: | Pathogenic
|
Disease: | Meesmann epithelial corneal dystrophy (MECD) |
Clinical Resources |
ClinVar ID: | 66126 |
KEGG disease ID: | H00726 |
OMIM ID: | 122100 |
COSMIC: | KRT12 |
DECIPHER: | KRT12 |
GeneTests: | KRT12 |
ASP siRNA details |
Mutant allele (5'->3'): | AAAAUCCUAAUGAUAGAUU
|
ASP-siRNA (As strand 3'->5'): | UUUUAGGAUUACUAUCUAA
|
Percentage efficacy of ASP-siRNA for mutant allele: | 96
|
Wild allele (5'->3'): | AAAAUCUUAAUGAUAGAUU
|
ASP-siRNA (As strand 3'->5'): | UUUUAGGAUUACUAUCUAA
|
Percentage efficacy of ASP-siRNA for wild allele: | 70
|
Relative difference: | 26
|
Wild siRNA details |
Wild allele (5'->3'): | AAAAUCUUAAUGAUAGAUU
|
Wild siRNA (As strand 3'->5'): | UUUUAGAAUUACUAUCUAA
|
Percentage efficacy of wild siRNA for wild allele: | 78
|
Wild allele (5'->3'): | AAAAUCUUAAUGAUAGAUU
|
ASP-siRNA (As strand 3'->5'): | UUUUAGGAUUACUAUCUAA
|
Percentage efficacy of Wild sirna for mutant allele: | 24
|
Relative difference : | 54
|
General information |
Mismatch incorporated in siRNA/Target: | siRNA |
Cell-line used: | Ptk2 |
Experimental technique used: | Dual luciferase reporter assay |
Transfection method: | Lipofectamine 2000 |
siRNA expression method: | MWG Biotech AG |
Post-transfection duration: | 48 hours |
Concentration used: | 0.01–6.25nM |
Reference: | 22174841 |
Delivery method: | Transfection |
'Article title: | Development of allele-specific therapeutic siRNA in Meesmann epithelial corneal dystrophy. |
'Authors: | Liao H, Irvine AD, Macewen CJ, Weed KH, Porter L, Corden LD, Gibson AB, Moore JE, Smith FJ, McLean WH, Moore CB. |
'Journal Reference: | PLoS One. 2011;6(12):e28582. doi: 10.1371/journal.pone.0028582. Epub 2011 Dec 12. |
'